<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02442622</url>
  </required_header>
  <id_info>
    <org_study_id>14-01059</org_study_id>
    <nct_id>NCT02442622</nct_id>
  </id_info>
  <brief_title>Effectiveness of Astym Treatment For de Quervain's Tenosynovitis</brief_title>
  <official_title>Effectiveness of Astym Treatment For de Quervain's Tenosynovitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NYU Langone Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NYU Langone Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine if the addition of Astym treatment to traditional therapy produces a more&#xD;
      positive outcome then traditional therapy alone for the treatment of de Quervain's&#xD;
      tenosynvitis. Two groups will be examined with one group receiving traditional therapy and&#xD;
      the other group receiving traditional therapy in addition to Astym treatment protocol.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2015</start_date>
  <completion_date type="Actual">April 29, 2019</completion_date>
  <primary_completion_date type="Actual">April 29, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric Rating Scale for Pain</measure>
    <time_frame>4.5 months</time_frame>
    <description>This scale is a single point scale from 0-10. The participant picks one number to represent their pain, where 0 represents no pain and 10 represents worst pain imaginable.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sequential Occupational Dexterity Assessment (SODA) Score</measure>
    <time_frame>1.5 months</time_frame>
    <description>This is a test to measure dexterity and bimanual abilities in activities of daily living. It includes 12 tasks with participants being scored on their ability, difficulty and pain during the task. Scores on the individual tasks are summed, and the range of the total SODA score is 0-108. A higher score indicates a higher dexterity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quick Dash Score</measure>
    <time_frame>4.5 months</time_frame>
    <description>It is a questionnaire that measures an individual's ability to complete tasks, absorb forces, and severity of symptoms. The QuickDASH tool uses a 5-point Likert scale from which the patient can select an appropriate number corresponding to his/her severity level/ function level. QuickDASH Scoring Formula = ([(sum of n responses)/n] -1)(25) where n represents the number of completed items. Higher scores indicate a greater level of disability and severity, whereas, lower scores indicate a lower level of disability. The score on both test ranges from 0 (no disability) to 100 (most severe disability).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>de Quervain's Disease</condition>
  <arm_group>
    <arm_group_label>Occupational therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Traditional therapy for de Quervain's Tenosynovitis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Occupational therapy with ASTYM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Traditional therapy for de Quervain's Tenosynovitis plus ASTYM</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Occupational therapy</intervention_name>
    <description>Occupational therapy for de Quervain's Tenosynovitis</description>
    <arm_group_label>Occupational therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Occupational therapy with ASTYM</intervention_name>
    <description>Occupational therapy for de Quervain's Tenosynovitis plus ASTYM</description>
    <arm_group_label>Occupational therapy with ASTYM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        i. Positive Finkelstein's test: The client will report pain over the first compartment of&#xD;
        the extensor retinaculum when the thumb is tucked in the hand and deviated ulnarly.&#xD;
&#xD;
        ii. Persistent symptoms for &gt;3 wks which have not resolved after an additional 3 weeks of&#xD;
        splinting&#xD;
&#xD;
        iii. A diagnosis by a physician of &quot;de Quervain's&quot;, &quot;fist compartment tenosynovitis&quot;, or&#xD;
        &quot;radial styloid tenosynovitis&quot;&#xD;
&#xD;
        iv. Patients must agree and comply to a predetermined splinting regimen&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        i. History of cortical steroid injection to affected wrist and/or thumb&#xD;
&#xD;
        ii. History of previous wrist trauma to affected limb&#xD;
&#xD;
        iii. Comorbidity such as carpal tunnel syndrome (CTS), radial tunnel syndrome,&#xD;
        osteoarthritis, rheumatoid arthritis, auto-immune disease or inflammatory conditions,&#xD;
        lateral epicondylitis or tendinopathies&#xD;
&#xD;
        iv. Clotting deficits&#xD;
&#xD;
        v. Positive Cozen's sign which would indicate intersection syndrome&#xD;
&#xD;
        vi. Post-partum mothers &lt;6 months and pregnant women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen VanLew, PhD, OTR/L</last_name>
    <role>Principal Investigator</role>
    <affiliation>NYU Langone Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NYU Langone Medical Center, Center for Musculoskeletal Care</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>May 8, 2015</study_first_submitted>
  <study_first_submitted_qc>May 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2015</study_first_posted>
  <results_first_submitted>August 25, 2020</results_first_submitted>
  <results_first_submitted_qc>September 16, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 9, 2020</results_first_posted>
  <last_update_submitted>September 16, 2020</last_update_submitted>
  <last_update_submitted_qc>September 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>de Quervain's disease</keyword>
  <keyword>de Quervain's tenosynovitis.</keyword>
  <keyword>ASTYM</keyword>
  <keyword>de Quervain's treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tenosynovitis</mesh_term>
    <mesh_term>De Quervain Disease</mesh_term>
  </condition_browse>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 27, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/22/NCT02442622/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Occupational Therapy</title>
          <description>Traditional therapy for de Quervain's Tenosynovitis&#xD;
Occupational therapy: Occupational therapy for de Quervain's Tenosynovitis</description>
        </group>
        <group group_id="P2">
          <title>Occupational Therapy With ASTYM</title>
          <description>Traditional therapy for de Quervain's Tenosynovitis plus ASTYM&#xD;
Occupational therapy with ASTYM: Occupational therapy for de Quervain's Tenosynovitis plus ASTYM</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Occupational Therapy</title>
          <description>Traditional therapy for de Quervain's Tenosynovitis&#xD;
Occupational therapy: Occupational therapy for de Quervain's Tenosynovitis</description>
        </group>
        <group group_id="B2">
          <title>Occupational Therapy With ASTYM</title>
          <description>Traditional therapy for de Quervain's Tenosynovitis plus ASTYM&#xD;
Occupational therapy with ASTYM: Occupational therapy for de Quervain's Tenosynovitis plus ASTYM</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="32"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43.85" spread="12.57"/>
                    <measurement group_id="B2" value="42.94" spread="14.28"/>
                    <measurement group_id="B3" value="43.40" spread="13.43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Numeric Rating Scale for Pain</title>
        <description>This scale is a single point scale from 0-10. The participant picks one number to represent their pain, where 0 represents no pain and 10 represents worst pain imaginable.</description>
        <time_frame>4.5 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Occupational Therapy</title>
            <description>Traditional therapy for de Quervain's Tenosynovitis&#xD;
Occupational therapy: Occupational therapy for de Quervain's Tenosynovitis</description>
          </group>
          <group group_id="O2">
            <title>Occupational Therapy With ASTYM</title>
            <description>Traditional therapy for de Quervain's Tenosynovitis plus ASTYM&#xD;
Occupational therapy with ASTYM: Occupational therapy for de Quervain's Tenosynovitis plus ASTYM</description>
          </group>
        </group_list>
        <measure>
          <title>Numeric Rating Scale for Pain</title>
          <description>This scale is a single point scale from 0-10. The participant picks one number to represent their pain, where 0 represents no pain and 10 represents worst pain imaginable.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.2" spread="2.5"/>
                    <measurement group_id="O2" value="2.1" spread="2.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sequential Occupational Dexterity Assessment (SODA) Score</title>
        <description>This is a test to measure dexterity and bimanual abilities in activities of daily living. It includes 12 tasks with participants being scored on their ability, difficulty and pain during the task. Scores on the individual tasks are summed, and the range of the total SODA score is 0-108. A higher score indicates a higher dexterity.</description>
        <time_frame>1.5 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Occupational Therapy</title>
            <description>Traditional therapy for de Quervain's Tenosynovitis&#xD;
Occupational therapy: Occupational therapy for de Quervain's Tenosynovitis</description>
          </group>
          <group group_id="O2">
            <title>Occupational Therapy With ASTYM</title>
            <description>Traditional therapy for de Quervain's Tenosynovitis plus ASTYM&#xD;
Occupational therapy with ASTYM: Occupational therapy for de Quervain's Tenosynovitis plus ASTYM</description>
          </group>
        </group_list>
        <measure>
          <title>Sequential Occupational Dexterity Assessment (SODA) Score</title>
          <description>This is a test to measure dexterity and bimanual abilities in activities of daily living. It includes 12 tasks with participants being scored on their ability, difficulty and pain during the task. Scores on the individual tasks are summed, and the range of the total SODA score is 0-108. A higher score indicates a higher dexterity.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107.33" spread="5.6"/>
                    <measurement group_id="O2" value="106.75" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Quick Dash Score</title>
        <description>It is a questionnaire that measures an individual's ability to complete tasks, absorb forces, and severity of symptoms. The QuickDASH tool uses a 5-point Likert scale from which the patient can select an appropriate number corresponding to his/her severity level/ function level. QuickDASH Scoring Formula = ([(sum of n responses)/n] -1)(25) where n represents the number of completed items. Higher scores indicate a greater level of disability and severity, whereas, lower scores indicate a lower level of disability. The score on both test ranges from 0 (no disability) to 100 (most severe disability).</description>
        <time_frame>4.5 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Occupational Therapy</title>
            <description>Traditional therapy for de Quervain's Tenosynovitis&#xD;
Occupational therapy: Occupational therapy for de Quervain's Tenosynovitis</description>
          </group>
          <group group_id="O2">
            <title>Occupational Therapy With ASTYM</title>
            <description>Traditional therapy for de Quervain's Tenosynovitis plus ASTYM&#xD;
Occupational therapy with ASTYM: Occupational therapy for de Quervain's Tenosynovitis plus ASTYM</description>
          </group>
        </group_list>
        <measure>
          <title>Quick Dash Score</title>
          <description>It is a questionnaire that measures an individual's ability to complete tasks, absorb forces, and severity of symptoms. The QuickDASH tool uses a 5-point Likert scale from which the patient can select an appropriate number corresponding to his/her severity level/ function level. QuickDASH Scoring Formula = ([(sum of n responses)/n] -1)(25) where n represents the number of completed items. Higher scores indicate a greater level of disability and severity, whereas, lower scores indicate a lower level of disability. The score on both test ranges from 0 (no disability) to 100 (most severe disability).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.72" spread="5.60"/>
                    <measurement group_id="O2" value="10.61" spread="12.05"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>up to 4.5 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Occupational Therapy</title>
          <description>Traditional therapy for de Quervain's Tenosynovitis&#xD;
Occupational therapy: Occupational therapy for de Quervain's Tenosynovitis</description>
        </group>
        <group group_id="E2">
          <title>Occupational Therapy With ASTYM</title>
          <description>Traditional therapy for de Quervain's Tenosynovitis plus ASTYM&#xD;
Occupational therapy with ASTYM: Occupational therapy for de Quervain's Tenosynovitis plus ASTYM</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Steve Vanlew, PhD</name_or_title>
      <organization>NYU Langone Health</organization>
      <phone>646-501-7707</phone>
      <email>Steve.Vanlew@nyulangone.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

